The Omics Standards Landscape: Building Bridges to Advance Drug Discovery and Clinical Trials Research

The Omics Standards Landscape: Building Bridges to Advance Drug Discovery and Clinical Trials Research

When

JavaScript Disabled
JavaScript Disabled
(Date and time are shown in your browser's local time zone)

Event Type

Join us for a thought-provoking virtual roundtable bringing together experts from across industry and academia to discuss the evolving role of omics standards in drug discovery, translational research, and clinical trials.

Speakers include:

  • Bron Kisler – The Genomics and Omics Standards Landscape
  • Adrian Czaban (Novo Nordisk) – CDISC Clinical Trial Use Case
  • Dr. Jonathan Keeney (BioCompute / GWU) – Overview of BioCompute and FDA collaboration

The session will feature short presentations, live audience polling, and an interactive Q&A exploring key challenges such as interoperability, regulatory alignment, and adoption of standards across the R&D pipeline.

This roundtable offers a unique opportunity to learn how omics data and standards are shaping the future of biomedical innovation.

 

Register below